+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dental Membrane and Bone Graft Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4911506
  • Report
  • November 2019
  • Region: Global
  • 259 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BioHorizons, Inc.
  • Collagen Matrix, Inc.
  • Dentsply Sirona, Inc.
  • Geistlich Pharma AG
  • Institut Straumann AG
  • Maxigen Biotech, Inc.
  • MORE
Dental Membrane and Bone Graft Substitutes Market - Scope of the Report

The report on the global dental membrane and bone graft substitutes market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global dental membrane and bone graft substitutes market for the period of 2017 - 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global dental membrane and bone graft substitutes market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global dental membrane and bone graft substitutes market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global dental membrane and bone graft substitutes market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global dental membrane and bone graft substitutes market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global dental membrane and bone graft substitutes market. The next section of the global dental membrane and bone graft substitutes report highlights the USPs, which include the regulatory scenarios for dental membrane and bone graft substitutes, globally, dental membrane and bone graft substitutes pipeline analysis, and potential mergers & acquisition in the global dental membrane and bone graft substitutes market.

The report delves into the competitive landscape of the global dental membrane and bone graft substitutes market. Key players operating in the global dental membrane and bone graft substitutes market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of the players profiled in the global dental membrane and bone graft substitutes market report.

Key Questions Answered in Global Dental Membrane and Bone Graft Substitutes Market Report
  • What is the sales/revenue projected to be generated by dental membrane and bone graft substitute products across all the regions during the forecast period?
  • What are the key trends in the dental membrane and bone graft substitutes market?
  • What are the major drivers, restraints, and opportunities in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue, globally, in 2027, and which product segment will expand at the fastest CAGR during the forecast period?
Dental Membrane and Bone Graft Substitutes Market - Research Objectives & Research Approach

The comprehensive report on the global dental membrane and bone graft substitutes market begins with an overview of the said market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global dental membrane and bone graft substitutes market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key dental membrane and bone graft substitute manufacturers has been mapped to ascertain the size of the global dental membrane and bone graft substitutes market in terms of value. The forecast presented here assesses the total revenue generated in the dental membrane and bone graft substitutes market. In order to provide an accurate forecast, we initiated by sizing up the current dental membrane and bone graft substitutes market with the help of the parent market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BioHorizons, Inc.
  • Collagen Matrix, Inc.
  • Dentsply Sirona, Inc.
  • Geistlich Pharma AG
  • Institut Straumann AG
  • Maxigen Biotech, Inc.
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary: Global Dental Membrane and Bone Graft Substitutes Market

5. Market Overview
5.1. Definition
5.2. Market Indicators
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunities

6. Market Outlook
6.1. Global Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast, 2017–2027
6.2. Global Dental Membrane and Bone Graft Substitutes Market Outlook
6.3. Dental Membrane and Bone Graft Substitutes Market – Key Product Launches
6.4. Dental Membrane and Bone Graft Substitutes Market – Strategic Acquisitions and Partnerships
6.5. Regulatory Approval Process
6.6. Porter’s Five Force Analysis
6.7. Value Chain Analysis
6.8. Clinical Trial Analysis

7. Global Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast, by Product
7.1. Introduction
7.2. Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Product, 2017–2027
7.2.1. Dental Membrane
7.2.1.1. Resorbable
7.2.1.2. Non-resorbable
7.2.2. Dental Bone Graft
7.2.2.1. Autograft
7.2.2.2. Allograft
7.2.2.3. Demineralized Bone Matrix
7.2.2.4. Xenograft
7.2.2.5. Synthetic Bone Graft Substitute
7.3. Market Attractiveness, by Product

8. Global Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast, by Material
8.1. Introduction
8.2. Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Material, 2017–2027
8.2.1. Hydrogel
8.2.2. Collagen
8.2.3. Polytetrafluoroethylene (PTFE)
8.2.4. Human Cells Sources
8.2.5. Other Species
8.2.6. Hydroxyapatite (HA)
8.2.7. Tricalcium Phosphate (TCP)
8.3. Market Attractiveness By Material

9. Global Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast, by End-user
9.1. Introduction
9.2. Dental Membrane and Bone Graft Substitutes Market Value Forecast, by End-user, 2017–2027
9.2.1. Hospitals
9.2.2. Dental Clinics
9.2.2.1. Individual Practice
9.2.2.2. Group Practice
9.2.3. Ambulatory Surgical Centers
9.3. Market Attractiveness, by Distribution Channel

10. Global Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast, by Region
10.1. Regional Outlook
10.2. Global Scenario
10.3. Introduction
10.4. Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
10.5. Market Attractiveness, by Region

11. North America Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast
11.1. Key Findings
11.2. North America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Product, 2017–2027
11.2.1. Dental Membrane
11.2.1.1. Resorbable
11.2.1.2. Non-resorbable
11.2.2. Dental Bone Graft
11.2.2.1. Autograft
11.2.2.2. Allograft
11.2.2.3. Demineralized Bone Matrix
11.2.2.4. Xenograft
11.2.2.5. Synthetic Bone Graft Substitute
11.3. North America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Material, 2017–2027
11.3.1. Hydrogel
11.3.2. Collagen
11.3.3. Polytetrafluoroethylene (PTFE)
11.3.4. Human Cells Sources
11.3.5. Other Species
11.3.6. Hydroxyapatite (HA)
11.3.7. Tricalcium Phosphate (TCP)
11.4. North America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Dental Clinics
11.4.2.1. Individual Practice
11.4.2.2. Group Practice
11.4.3. Ambulatory Surgical Centers
11.5. North America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. U.S.
11.5.2. Canada
11.6. North America Dental Membrane and Bone Graft Substitutes Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Material
11.6.3. By End-user
11.6.4. By Country

12. Europe Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast
12.1. Key Findings
12.2. Europe Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Product, 2017–2027
12.2.1. Dental Membrane
12.2.1.1. Resorbable
12.2.1.2. Non-resorbable
12.2.2. Dental Bone Graft
12.2.2.1. Autograft
12.2.2.2. Allograft
12.2.2.3. Demineralized Bone Matrix
12.2.2.4. Xenograft
12.2.2.5. Synthetic Bone Graft Substitute
12.3. Europe Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Material, 2017–2027
12.3.1. Hydrogel
12.3.2. Collagen
12.3.3. Polytetrafluoroethylene (PTFE)
12.3.4. Human Cells Sources
12.3.5. Other Species
12.3.6. Hydroxyapatite (HA)
12.3.7. Tricalcium Phosphate (TCP)
12.4. Europe Dental Membrane and Bone Graft Substitutes Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Dental Clinics
12.4.2.1. Individual Practice
12.4.2.2. Group Practice
12.4.3. Ambulatory Surgical Centers
12.5. Europe Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. U.K.
12.5.2. Germany
12.5.3. France
12.5.4. Italy
12.5.5. Spain
12.5.6. Rest of Europe
12.6. Europe Dental Membrane and Bone Graft Substitutes Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Material
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Asia Pacific Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast
13.1. Key Findings
13.2. Asia Pacific Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Product, 2017–2027
13.2.1. Dental Membrane
13.2.1.1. Resorbable
13.2.1.2. Non-resorbable
13.2.2. Dental Bone Graft
13.2.2.1. Autograft
13.2.2.2. Allograft
13.2.2.3. Demineralized Bone Matrix
13.2.2.4. Xenograft
13.2.2.5. Synthetic Bone Graft Substitute
13.3. Asia Pacific Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Material, 2017–2027
13.3.1. Hydrogel
13.3.2. Collagen
13.3.3. Polytetrafluoroethylene (PTFE)
13.3.4. Human Cells Sources
13.3.5. Other Species
13.3.6. Hydroxyapatite (HA)
13.3.7. Tricalcium Phosphate (TCP)
13.4. Asia Pacific Dental Membrane and Bone Graft Substitutes Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Dental Clinics
13.4.2.1. Individual Practice
13.4.2.2. Group Practice
13.4.3. Ambulatory Surgical Centers
13.5. Asia Pacific Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. China
13.5.2. India
13.5.3. Japan
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Dental Membrane and Bone Graft Substitutes Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Material
13.6.3. By End-user
13.6.4. By Country/Sub-region

14. Latin America Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast
14.1. Key Findings
14.2. Latin America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Product, 2017–2027
14.2.1. Dental Membrane
14.2.1.1. Resorbable
14.2.1.2. Non-resorbable
14.2.2. Dental Bone Graft
14.2.2.1. Autograft
14.2.2.2. Allograft
14.2.2.3. Demineralized Bone Matrix
14.2.2.4. Xenograft
14.2.2.5. Synthetic Bone Graft Substitute
14.3. Latin America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Material, 2017–2027
14.3.1. Hydrogel
14.3.2. Collagen
14.3.3. Polytetrafluoroethylene (PTFE)
14.3.4. Human Cells Sources
14.3.5. Other Species
14.3.6. Hydroxyapatite (HA)
14.3.7. Tricalcium Phosphate (TCP)
14.4. Latin America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Dental Clinics
14.4.2.1. Individual Practice
14.4.2.2. Group Practice
14.4.3. Ambulatory Surgical Centers
14.5. Latin America Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Country/Sub-region, 2017–2027
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Latin America Dental Membrane and Bone Graft Substitutes Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Material
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Middle East & Africa Dental Membrane and Bone Graft Substitutes Market Analysis and Forecast
15.1. Key Findings
15.2. Middle East & Africa Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Product, 2017–2027
15.2.1. Dental Membrane
15.2.1.1. Resorbable
15.2.1.2. Non-resorbable
15.2.2. Dental Bone Graft
15.2.2.1. Autograft
15.2.2.2. Allograft
15.2.2.3. Demineralized Bone Matrix
15.2.2.4. Xenograft
15.2.2.5. Synthetic Bone Graft Substitute
15.3. Middle East & Africa Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Material, 2017–2027
15.3.1. Hydrogel
15.3.2. Collagen
15.3.3. Polytetrafluoroethylene (PTFE)
15.3.4. Human Cells Sources
15.3.5. Other Species
15.3.6. Hydroxyapatite (HA)
15.3.7. Tricalcium Phosphate (TCP)
15.4. Middle East & Africa Dental Membrane and Bone Graft Substitutes Market Value Forecast, by End-user, 2017–2027
15.4.1. Hospitals
15.4.2. Dental Clinics
15.4.2.1. Individual Practice
15.4.2.2. Group Practice
15.4.3. Ambulatory Surgical Centers
15.5. Middle East & Africa Dental Membrane and Bone Graft Substitutes Market Value Forecast, by Country/Sub-region, 2017–2027
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. Israel
15.5.4. Rest of Middle East & Africa
15.6. Middle East & Africa Dental Membrane and Bone Graft Substitutes Market Attractiveness Analysis
15.6.1. By Product
15.6.2. By Material
15.6.3. By End-user
15.6.4. By Country/Sub-region

16. Competition Landscape
16.1. Competition Matrix
16.2. Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. Institut Straumann AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Strategic Overview
16.3.1.5. SWOT Analysis
16.3.2. Danaher Corporation (Nobel Biocare Services AG)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Strategic Overview
16.3.2.5. SWOT Analysis
16.3.3. Geistlich Pharma AG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Strategic Overview
16.3.3.5. SWOT Analysis
16.3.4. Zimmer Biomet Holdings, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Strategic Overview
16.3.4.5. SWOT Analysis
16.3.5. Integra LifeSciences Holdings Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Strategic Overview
16.3.5.5. SWOT Analysis
16.3.6. Dentsply Sirona, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Strategic Overview
16.3.6.5. SWOT Analysis
16.3.7. BioHorizons, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Strategic Overview
16.3.7.5. SWOT Analysis
16.3.8. NovaBone Products, LLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Strategic Overview
16.3.8.5. SWOT Analysis
16.3.9. Collagen Matrix, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Strategic Overview
16.3.9.5. SWOT Analysis
16.3.10. Maxigen Biotech, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Strategic Overview
16.3.10.5. SWOT Analysis
16.3.11. Osteogenics Biomedical
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Financial Overview
16.3.11.3. Product Portfolio
16.3.11.4. Strategic Overview
16.3.11.5. SWOT Analysis
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Institut Straumann AG
  • Danaher Corporation (Nobel Biocare Services AG)
  • Geistlich Pharma AG
  • Zimmer Biomet Holdings, Inc.
  • Integra LifeSciences Holdings Corporation
  • Dentsply Sirona, Inc.
  • BioHorizons, Inc.
  • NovaBone Products, LLC
  • Collagen Matrix, Inc.
  • Maxigen Biotech, Inc.
  • Osteogenics Biomedical
Note: Product cover images may vary from those shown
Adroll
adroll